FDA
-
-
-
-
-
-
-
Avant Technologies revises clinical trial protocol after FDA meeting
-
-
-
-
-
-
-
Avant Technologies Signs Letter of Intent for a Business Combination
-
-
-
-
-
-
-
Avant Technologies and Ainnova Request Pre-Submission Meeting with US FDA for VisionAI Platform Technology
-
-
-
-
-
-
-
Avant Technologies to Play Key Role in Ainnova's U.S. FDA Clinical Study for Its Vision AI Platform
-
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

